1. Home
  2. BRTX

as of 12-15-2025 10:22am EST

$1.09
$0.02
-1.90%
Stocks Health Care Managed Health Care Nasdaq

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Chart Type:
Time Range:
Founded: 1997 Country:
United States
United States
Employees: N/A City: MELVILLE
Market Cap: 9.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 79.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.48 EPS Growth: N/A
52 Week Low/High: $0.98 - $2.55 Next Earning Date: 11-12-2025
Revenue: $383,400 Revenue Growth: 1.70%
Revenue Growth (this year): 112.14% Revenue Growth (next year): 139.81%

AI-Powered BRTX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 20 hours ago

AI Recommendation

hold
Model Accuracy: 67.79%
67.79%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest BioRestorative Therapies Inc. (NV) News

BRTX Breaking Stock News: Dive into BRTX Ticker-Specific Updates for Smart Investing

All BRTX News

Share on Social Networks: